With up to 30-50% annual growth in adverse event cases, how are pharmacovigilance teams managing with today’s constrained budgets,…
Learn More
South Korean Contract Research Organization, LSK, spoke in a webinar with ArisGlobal to address the pressures of modernizing pharmacovigilance…
Learn More
The Future of Drug Safety Intelligence The future of safety intelligence is closer…
Learn More
As part of our commitment to providing the most robust out-of-the-box (OOTB) offering to our safety customers, we recently…
Learn More
There’s no doubt that the pharmaceutical industry is well into its ‘age of automation’. A…
Learn More
Your team’s workload grows by the day. The volume of Safety cases you’re managing increases significantly every year. All the same, the internal pressure to…
Learn More
The coronavirus pandemic ushered in a new era of public scrutiny for the pharmaceutical industry. The general population was…
Learn More
Digital Impact on the Drug Safety Space Digital transformation, automation, and analytics were top of mind when ArisGlobal recently…
Learn More
It’s hard to think about COVID-19 and vaccine production, without reflecting on the speed, safety, and risks involved…
Learn More
On June 9th, 2020 ArisGlobal held a webinar titled “Pharmacovigilance and Digital Transformation: Stepping…
Learn More
ArisGlobal Acquires Leading Regulatory Data Governance Solution, SPORIFY